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Senile cardiac amyloidosis is a form of primary amyloidosis affecting mainly 
the heart  (1,  2), but small deposits are often found in pulmonary vessels and 
sometimes in vessels of other organs such as the pancreas or the kidneys. Senile 
cardiac amyloidosis has been found in 12.5% of autopsied persons, and after the 
age of 90 such a high frequency as 50% has been reported (2). Although much 
more frequent than other types of systemic amyloidosis,  this diagnosis is only 
rarely established before death and no studies have been reported on the nature 
of senile cardiac amyloid. In the present paper we have characterized, from five 
different patients with senile cardiac amyloidosis (SCA), by immunological and 
immunochemical techniques an amyloid fibril protein, AscA, which appears to 
be unique to this type of amyloid,  and different from other types of amyloid 
proteins so far characterized. 
Materials and Methods 
A myloid Tissues and Isolation of  Amyloid Fibrils.  Heart tissues rich in amyloid were from one 
female and four male patients [H.  L.  74 yr (kindly provided by Dr.  Hans Nordgren,  Lund); 84, 
82 yr; 120, 90 yr; 335, 85 yr; and 402, 89 yr]. The patients had all suffered from heart insufficiency or 
atrial fibrillation but amyloidosis was never suspected.  The autopsies revealed massive amyloi- 
dosis of the heart (weights, 400-950 g) and small deposits of amyloid in pulmonary, renal, and in 
one case also of liver vessels. 
Amyloid fibrils were isolated as described before (3, 4), with the exception that the main part of 
the amyloid was found in the top of the residual pellet after centrifugation and was less soluble 
than other amyloid fibrils in water.  Previously characterized primary  and secondary  amyloid 
fibril proteins were used as controls. Degraded amyloid (DAM) was made by treatment with 0.1 M 
NaOH (3). 
Immunological Technique Methods.  Rabbit antisera were made against DAM preparations of 
cardiac amyloid fibrils (H.  L.) in two rabbits and against amyloid protein AA, various amyloid 
proteins of immunoglobulin origin, and an amyloid-related high molecular weight protein (void 
volume peak material) (4, 5).  Antisera were absorbed with pooled human serum. 
Gel Filtration.  Amyloid fibrils (15 mg/ml) were dissolved in 6 M guanidine HC1 in 0.1 M Tris/ 
HC1 buffer, pH 8.0,  with 0.1  M  dithiothreitol. After centrifugation the clear solutions were gel 
filtered through a 2.6 x  70 cm Sepharose 6 B column equilibrated and eluted with 5 M guanidine/ 
HC1.  Pooled fractions were desalted through a short Sephadex G 25 column equilibrated with 10% 
formic  acid  or  by exhaustive  dialysis  against  water.  The  major subunit  protein  was  purified 
further by rechromatography through a  1.6 ×  100 cm Sephadex G 150 column equilibrated with 5 
M guanidine/HC1 (4,  5). 
Electron Microscopy.  Precipitates  occurring after dialysis of fractions from the separations 
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were suspended in water and placed on Formvar coated copper grids and air dried after the excess 
had been blotted off. The specimens were negatively contrasted with 2% phosphotungstic acid, pI:I 
5.3,  and studied in a Jeol JMC 100 electron microscope at 80 kV (6). 
Results 
Antigenic  Analysis  of DAM Fibrils.  The  anti-amyloid  H.  L.  antiserum 
obtained by immunization  with the DAM preparation  of amyloid fibrils of the 
senile amyloidosis H. L. showed one line of precipitation with DAM H. L. and 
the DAM preparations  of the four other senile cardiac amyloids (84,  120,  335, 
and  402).  The  precipitation  lines  fused completely  (Fig.  l a).  In  contrast,  no 
precipitation  was obtained when the anti-amyloid  H. L. antiserum was tested 
against DAM preparations of amyloid fibrils purified from the heart of a young 
patient with primary amyloidosis or a  panel of DAM preparations of primary, 
myeloma-associated or secondary amyloids, nor did these preparations  inhibit 
the reaction between DAM preparations from the cardiac amyloid fibrils and the 
anti-DAM H. L. antiserum.  Similarly, normal human serum or an extract from 
normal heart treated as the DAM preparations,  gave no reaction or inhibition. 
Furthermore,  antiserum  against protein AA and several amyloid fibril pro- 
teins of immunoglobulin  light  chain  origin  did not react with any of the five 
DAM preparations of the senile cardiac amyloids (Table I).  On the other hand, 
the  high  molecular  weight  material  (4,  5)  was  present  in  all  five  cardiac 
amyloids as they also were in the amyloid preparation  from the heart  of the 
younger patient with primary amyloidosis. This high molecular weight protein 
which probably is a secondary protein in relation to the amyloid process can be 
isolated from almost all types of amyloids and may represent a normal protein of 
vessel walls (unpublished observation). 
Characterization of the Purified Amyloid Proteins.  The amounts of amyloid 
fibril  material  from  two  patients  were  sufficient  for  further  analysis.  Their 
elution patterns  upon gel filtration  were almost identical  with  a  high  initial 
peak,  a  broader  intermediate  area,  and  a  small  but distinct  retarded  second 
peak  (Fig.  1 b).  In  contrast,  preparations  from nonamyloidotic hearts  gave a 
similar large and broad initial peak and an intermediate  area,  but the second 
small and retarded peak was absent. This second peak material,  only obtained 
from  the  senile  amyloidotic hearts,  corresponded to  a  mot  wt of about  6,000 
daltons when estimated by mobility in sodium dodecyl sulfate electrophoresis 
(7). 
When  tested  against  anti-DAM  H.  L.  antiserum  in  immunodiffusion,  the 
6,000  mol  wt  proteins  of amyloids  H.  L.  and  335  each  showed  one  line  of 
precipitation,  which fused completely with  the  lines  obtained  with  the  DAM 
preparations (Fig.  1 a). Some material which reacted with anti-DAM H. L. was 
also detected in the broad intermediate  area of the gel filtration but not in the 
first peak. The amino acid compositions of the subunit proteins of the amyloids 
H. L. and 335 were almost identical and differ significantly from that of protein 
AA (Table II). 
Additional Experiments.  Additional  experiments  were performed to  study 
whether the isolated cardiac amytoid fibril proteins could form fibrils in vitro. 
The  precipitate  obtained  when  a  solution  of the  pure  subunit  protein  was 
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FIo.  1.  (a) Double immunodiffusion with anti-DAM H. L. in central well. 1 and 4, protein 
subunit of H. L. (peak II in Fig. 1 b); 2, DAM 402; 3, DAM of material extracted from normal 
heart; 5,  DAM H.  L.; 6, DAM 335. (b) Elution profiles of DAM H. L. and DAM 335, from a 
Sepharose 6B column (2.6  x  70 cm). Elution buffer was 5 M guanidine/HC1 as described in 
Materials and Methods. Horizontal bar in second small peak indicates fractions pooled for 
antigenic and immunochemical characterization of senile cardiac amyloid fibril subunit. 
width of about 40/~.  The fibrils were vawy and not as rigid as native amyloid 
fibrils.  The  precipitate  had  affinity  to  Congo  red  but  did  not  show  green 
birefringence. 
Discussion 
Senile  systemic  amyloidosis  appears  to  affect  especially  the  heart.  Other 
deposits are small and mostly not symptom giving (1, 2). Furthermore, as shown 634  WESTERMARK  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
Reaction Pattern of Senile Cardiac Amyloid with Different Amyloid 
A ntisera 
Antiserum against: 
AA  AklV  A~V  Asc  A  Vo 
Senile cardiac amyloid 
DAM preparation 
(H. L., 84,  120,  335, 402)  -  -  +  + 
Peak I*  (H, L. and 335~  -  -  -  + 
Peak II  (H. L. and 335)  -  -  + 
Controls 
DAM secondary amyloid  +  -  -  + 
DAM primary amyloid (AxIV)  +  + 
DAM  primary amyloid (A~  V~  -  +  -  + 
* Peak I  is material from the initial high void volume peak and peak II is material from the last small 
peak  indicated by horizontal bar in Fig.  1 b 
in this paper,  the major subunit protein of senile cardiac amyloid is unique to 
this  type of amyloid.  Thus,  the  subunit  proteins  from the  five senile  cardiac 
amyloids were identical when tested against an antiserum to one of them. This 
antiserum  failed to react  with  any other amyloids tested,  with  normal  heart 
extracts, or normal serum. Furthermore,  antisera against different other major 
amyloid proteins  did  not  react  with  the  unique  senile  cardiac  amyloid fibril 
protein.  Although  a  serum protein,  SAA,  (8-11) structurally closely related to 
protein  AA  (4,  5,  12)  of secondary  amyloidosis is  found  in  increasingly  high 
amount  with  age  (10,  11),  no  protein  AA-like  material  was  found  in  senile 
cardiac amyloid. The possibility of light chain fragments which are often found 
in  typical  primary  amyloidosis  is  not  totally  excluded.  However,  no  cross- 
reactions have been encountered  with  a  variety of antisera  to light  chains  or 
other amyloids.  It would also be rather unexpected to find the same immuno- 
globulin  chain  in  the  amyloid  fibrils  of five different  patients  only  selected 
because they had SCA. Therefore,  the senile cardiac amyloid protein subunit, 
termed protein ASCA, appears to be a unique protein to this type of amyloidosis. 
It should be noted that tryptophane is present as in all other systemic amyloids 
(13). 
The yield of the subunit protein Asc A from the cardiac amyloid was only about 
10%, probably because the protein is even more insoluble than the other amyloid 
proteins.  The  cardiac  amyloid  materials  were  also  more  contaminated  with 
other proteins, possibly myofibrillar proteins, than other amyloids. The conclu- 
sion that  the  eluted protein  subunit  AscA is  amyloid related  is based on the 
comparison with the elution pattern of material extracted from normal hearts, 
where no similar peak was seen at gel filtration,  and where no antigenic cross- 
reaction could be found with the  amyloid subunit  protein,  AscA. The  subunit 
protein, although immunologically and chemically different from other amyloid 
fibril proteins has a low molecular weight like other amyloid proteins.  Finally, 
the amyloid protein Asc A can make fibrils in vitro. The reason why the fibrils 
precipitated in vitro, although taking up Congo red, did not show green birefrin- 
gence is unclear.  However,  as is  seen with  some other amyloid proteins,  the 
formation of fibrils in vitro is difficult and such fibrils do not totally resemble the 
native amyloid fibrils, possibly because the molecular arrangement is not that of WESTERMARK  ET  AL.  BRIEF  DEFINITIVE  REPORT  635 
TABLE II 
Amino Acid Composition of the Subunit Protein of Senile Heart 
Amyloid Fibrils from Two Patients* 
HL  335  AA 
Asp  8.1  7.3  10A 
Thr  8.1  7.9  0.3 
Ser  9.0  8.3  5.2 
Glu  12.4  11.7  6.1 
Pro  5.4  5.6  1.2 
Gly  8.5  7.7  8.6 
Ala  8.7  9.1  11.7 
Cys/2~  0.7  0,9  0.2 
Val  7.8  7,0  1.1 
Met  0.7  I.l  1.9 
Ile  4,6  4.6  2.8 
Leu  6,7  6.7  1.4 
Tyr  4,3  4.6  4.0 
Phe  3.4  3.9  6.5 
His  3.1  3.3  1.9 
Lys  4.2  6.1  2.1 
Arg  4.3  4,2  7.9 
Trp  ND§  ND§  1.3 
* Values expressed as residues/100  residues found,  as compared with protein AA. 
$ Determined as cysteic acid aider oxidation. 
§ ND, not determined, but typical absorption spectrum for tryptophan was recorded. 
a perfect fl-pleated sheet, typical of the native amyloid fibrils (14). The protein 
concentration is also of utmost importance for the in vitro formation of fibrils 
with properties of amyloid (10). Further studies are presently being performed to 
characterize the amyloid fibril protein Asc A of SCA in more detail. 
Summary 
A protein, Asc A, is isolated from amyloid fibrils extracted from heart tissue of 
five different patients with senile cardiac amyloidosis (SCA).  The proteins of all 
five patients showed immunological identity when reacted with an antiserum 
raised against one of the proteins.  In contrast, no reaction was obtained with 
antisera against a variety of other amyloid proteins. The antiserum against the 
subunit protein of senile cardiac amyloid did not react with any other amyloid 
preparations tested, nor with extracts of normal heart tissue. Thus, the subunit 
protein appeared to be unique to senile heart amyloid. The protein could form 
fibrils  in  vitro,  had  a  mol  wt  of about  6,000  daltons  and  the  amino  acid 
compositions investigated in two cases showed extensive similarities but were 
clearly different from that of protein AA of secondary amyloid fibrils. 
Received for publication 11  March 1977. 
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